Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,711 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke.
Wu S, Mair G, Cohen G, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Liu M, Lindley RI, Sandercock PAG, Wardlaw JM; IST-3 Collaborative Group. Wu S, et al. Among authors: cohen g. Stroke Vasc Neurol. 2021 Jun;6(2):238-243. doi: 10.1136/svn-2020-000569. Epub 2020 Nov 27. Stroke Vasc Neurol. 2021. PMID: 33246970 Free PMC article.
Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.
Wardlaw JM, von Kummer R, Carpenter T, Parsons M, Lindley RI, Cohen G, Murray V, Kobayashi A, Peeters A, Chappell F, Sandercock PA. Wardlaw JM, et al. Among authors: cohen g. Int J Stroke. 2015 Aug;10(6):956-68. doi: 10.1111/j.1747-4949.2012.00946.x. Epub 2013 Jan 22. Int J Stroke. 2015. PMID: 23336348 Free article. Clinical Trial.
Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, Sandercock P; IST-3 Collaborative Group. Whiteley WN, et al. Among authors: cohen g. Stroke. 2014 Apr;45(4):1000-6. doi: 10.1161/STROKEAHA.113.004362. Epub 2014 Mar 6. Stroke. 2014. PMID: 24603072 Free PMC article. Clinical Trial.
Alteplase for ischaemic stroke--responses.
Sandercock P, Lindley R, Wardlaw JM, Murray G, Whiteley W, Cohen G. Sandercock P, et al. Among authors: cohen g. Lancet. 2014 Aug 23;384(9944):660-1. doi: 10.1016/S0140-6736(14)61386-6. Lancet. 2014. PMID: 25152266 No abstract available.
Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke Trial.
Mair G, von Kummer R, Adami A, White PM, Adams ME, Yan B, Demchuk AM, Farrall AJ, Sellar RJ, Ramaswamy R, Mollison D, Boyd EV, Rodrigues MA, Samji K, Baird AJ, Cohen G, Sakka E, Palmer J, Perry D, Lindley R, Sandercock PA, Wardlaw JM; IST-3 Collaborative Group. Mair G, et al. Among authors: cohen g. Neuroradiology. 2015 Jan;57(1):1-9. doi: 10.1007/s00234-014-1441-0. Epub 2014 Oct 7. Neuroradiology. 2015. PMID: 25287075 Free PMC article. Clinical Trial.
Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis.
Khatri P, Tayama D, Cohen G, Lindley RI, Wardlaw JM, Yeatts SD, Broderick JP, Sandercock P; PRISMS and IST-3 Collaborative Groups. Khatri P, et al. Among authors: cohen g. Stroke. 2015 Aug;46(8):2325-7. doi: 10.1161/STROKEAHA.115.009951. Epub 2015 Jun 23. Stroke. 2015. PMID: 26106113 Clinical Trial.
2,711 results